Skip to main content

and
  1. No Access

    Chapter and Conference Paper

    Sequential Chemotherapy with Mitoxantrone, Etoposide and Cytarabine for Previously Treated Acute Myeloid Leukemia: EMA 86 Regimen

    EMA 86 regimen, associating mitoxantrone, 12 mg/m2/day on days 1–3, etoposide, 200 mg/m2/day as a continuous infusion on days 8–10 and cytarabine, 500 mg/m2/day as a continuous infusion on days 1–3 and 8–10, was ...

    Eric Archimbaud, Xavier Thomas, Véronique Leblond in Acute Leukemias V (1996)